NGEx Minerals Ltd. ("NGEx Minerals" "NGEx" or the "Company") (TSX: NGEX) (OTCQX: NGXXF) is pleased to report its results for ...

Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study ...

FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, ...

In this conversation, Agrawal explains why Peak XV resisted selling in multiple up-rounds, how early product calls set Groww ...

A 210-unit attainable-housing building that for decades had been a hotel but went into foreclosure last year has been sold to ...

Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...

Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Mount Logan Capital’s Third Quarter 2025 Results Conference ...

PetVivo Holdings, Inc. ( OTCPK:PETV) Q2 2026 Earnings Call November 14, 2025 5:00 PM EST ...

Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in ...